Steve Greenway has a Bachelor of Science degree in Biology from Eastern Michigan University. Steve has extensive experience in various roles within the biotech and pharmaceutical industries, including positions at Vesigen Therapeutics, Grand River Aseptic Manufacturing, SoloHill Engineering, Aastrom Biosciences, Keracure, Nephros Therapeutics, and PFIZER GLOBAL RESEARCH AND DEVELOPMENT. In their current role at Vesigen Therapeutics, Steve serves as the Director of Upstream Process Development.
July 1, 2023 - present
October, 2021